Retreatment

The therapy of the same disease in a patient, with the same agent or procedure repeated after initial treatment, or with an additional or alternate measure or follow-up. It does not include therapy which requires more than one administration of a therapeutic agent or regimen. Retreatment is often used with reference to a different modality when the original one was inadequate, harmful, or unsuccessful.

Also Known As:

Networked: 3237 relevant articles (301 outcomes, 401 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1.	Starke, Robert M: 16 articles (01/2022 - 08/2012)
2.	Jabbour, Pascal: 14 articles (01/2022 - 08/2012)
3.	Albuquerque, Felipe C: 12 articles (10/2022 - 01/2006)
4.	Levy, Elad I: 11 articles (12/2022 - 08/2009)
5.	Barber, Matthew D: 11 articles (11/2021 - 03/2008)
6.	Siddiqui, Adnan H: 10 articles (04/2022 - 03/2010)
7.	Bradley, Megan S: 10 articles (01/2022 - 01/2018)
8.	Paraiso, Marie Fidela R: 10 articles (01/2022 - 03/2008)
9.	Richter, Holly E: 10 articles (01/2021 - 05/2007)
10.	Hanel, Ricardo A: 9 articles (12/2022 - 08/2009)

Related Diseases

1.	Chronic Hepatitis C 12/01/2003 - "OBJECTIVES: To investigate the efficacy of prolonged IFN retreatment for 3 years in chronic hepatitis C patients with high viral load and IFN treatment-resistant genotype 1b. " 05/01/1997 - "In conclusion, this combination treatment was more effective than retreatment with IFN-alpha, alone, in inducing sustained biochemical remission of chronic hepatitis C that was resistant to a previous course of IFN-alpha. " 08/01/2018 - "The present case report indicated a case in which GZR/EBR was effective for the retreatment of a patient with a history of failed LDV/SOF treatment and chronic hepatitis C. " 10/01/2019 - "This study establishes the efficacy of GLE/PIB as retreatment in Japanese patients with GT2 chronic hepatitis C not responding to SOF + RBV." 11/01/1997 - "The aim of this study was to define the efficacy of IFN retreatment in chronic hepatitis C. "
2.	Infections 01/01/2020 - "Retreatment with 3D + 0SOF + RBV was highly effective and safe in patients with chronic HCV GT1b infection who failed previous use of NS5A inhibitors. " 01/01/2001 - "pylori infection, but whether these regimens are as effective when used for retreatment is unknown. " 01/01/2013 - "Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: role of an aggressive approach." 02/07/2020 - "The 10 studies showed the importance of surgical root canal retreatment as a treatment option in removing infections within the root canal system and its efficiency in periapical tissue healing. " 08/01/2016 - "A total of 120 patients were selected for the study and divided broadly into two groups: Group I containing patients with primary infection and group II containing patients in which retreatment was required. "
3.	Aneurysm (Aneurysms) 04/01/2021 - "All patients underwent successful retreatment of the recurrent aneurysm with good outcome. " 02/01/2018 - "At the longest follow up of 6 months or greater, 83.3% of the aneurysms were stable-to-improved in the Raymond occlusion classification, 8.3% were found to have minor recanalization not requiring retreatment, and 8.3% required retreatment due to significant recanalization. " 10/01/2005 - "The grade of aneurysm occlusion at 6 months improved in 4 patients, remained stable in 15, and deteriorated in 6. Three patients needed retreatment because of a major aneurysm recanalization. " 01/01/2021 - "Conclusions: Endovascular retreatment for recurrent aneurysms after initial endovascular treatment might be safe and effective. " 06/01/2020 - "Endovascular retreatment of recurrent previously coiled aneurysms is safe and effective even though advanced embolization techniques are frequently involved especially for large and giant aneurysms."
4.	Neoplasms (Cancer) 03/01/2004 - "The improvement in tumor target coverage and significant sparing of adjacent critical structures allow the feasibility of IMRT as a retreatment option for recurrent NPC after initial conventional RT. " 06/01/2014 - "Tumor volumes >300 mL were predictive for hepatic recurrence, suggesting that increased dosing or retreatment of these lesions may lead to improved hepatic control of disease and better patient outcomes." 01/18/2022 - "It is useful to evaluate the efficacy of ablation immediately after treatment to provide guidance for the retreatment of residual unablated tumors. " 10/01/1989 - "As many of the salivary gland malignancies we see are of the recurrent type, the following study was done to determine the efficacy of a vigorous attempt at retreatment. " 01/01/2018 - "Our results show improved tumor control using a prescription of doses ≥46 Gy in retreatment setting."
5.	Disease Progression 01/01/2020 - "For disease progression after PD-(L)1 inhibitors, 13 studies evaluated anti-PD-(L)1 retreatment. " 12/01/2023 - "EFS was defined as the time from diagnosis to the occurrence of disease progression after initial treatment, retreatment, or death. " 10/01/2023 - "Given the initial beneficial antitumor response, retreatment was discussed during disease progression. " 01/01/2023 - "All patients who failed TFR regained DMR after retreatment with TKI, with no disease progression reported. " 01/01/2023 - "However, ICI retreatment was ineffective in patients with disease progression during the initial ICI treatment."

Related Drugs and Biologics

1.	Interferons
2.	Infliximab (Remicade)
3.	Ribavirin (Virazole)
4.	Interferon-alpha (Interferon Alfa)
5.	Rituximab (Mabthera)
6.	Bortezomib (Velcade)
7.	Platinum
8.	Gefitinib (Iressa)
9.	Immune Checkpoint Inhibitors
10.	Monoclonal Antibodies

Related Therapies and Procedures

1.	Therapeutics
2.	Drug Therapy (Chemotherapy)
3.	Aftercare (After-Treatment)
4.	Laser In Situ Keratomileusis (LASIK)
5.	Stents